<html xmlns:o="urn:schemas-microsoft-com:office:office"
xmlns:w="urn:schemas-microsoft-com:office:word"
xmlns="http://www.w3.org/TR/REC-html40">


<!-- Mirrored from medicain.net/DUOC THU QUOC GIA/Dacarbazin.htm by HTTrack Website Copier/3.x [XR&CO'2013], Tue, 25 Mar 2014 18:06:49 GMT -->
<head>
<meta http-equiv=Content-Type content="text/html; charset=windows-1252">
<meta name=ProgId content=Word.Document>
<meta name=Generator content="Microsoft Word 11">
<meta name=Originator content="Microsoft Word 11">
<link rel=File-List href="javascript:if(confirm('http://www.vietstarse.com/duocthu/Documents/Dacarbazin_files/filelist.xml  \n\nThis file was not retrieved by Teleport Pro, because the server reports that this file cannot be found.  \n\nDo you want to open it from the server?'))window.location='http://www.vietstarse.com/duocthu/Documents/Dacarbazin_files/filelist.xml'" tppabs="http://www.vietstarse.com/duocthu/Documents/Dacarbazin_files/filelist.xml">
<title>DACARBAZIN</title>
<!--[if gte mso 9]><xml>
 <o:DocumentProperties>
  <o:Author>VIETSTAR</o:Author>
  <o:LastAuthor>Ghost</o:LastAuthor>
  <o:Revision>3</o:Revision>
  <o:TotalTime>2</o:TotalTime>
  <o:Created>2006-08-08T14:04:00Z</o:Created>
  <o:LastSaved>2006-08-08T14:22:00Z</o:LastSaved>
  <o:Pages>2</o:Pages>
  <o:Words>1119</o:Words>
  <o:Characters>6381</o:Characters>
  <o:Company>VS</o:Company>
  <o:Lines>53</o:Lines>
  <o:Paragraphs>14</o:Paragraphs>
  <o:CharactersWithSpaces>7486</o:CharactersWithSpaces>
  <o:Version>11.5606</o:Version>
 </o:DocumentProperties>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:WordDocument>
  <w:DoNotHyphenateCaps/>
  <w:PunctuationKerning/>
  <w:ValidateAgainstSchemas>false</w:ValidateAgainstSchemas>
  <w:SaveIfXMLInvalid>false</w:SaveIfXMLInvalid>
  <w:IgnoreMixedContent>false</w:IgnoreMixedContent>
  <w:AlwaysShowPlaceholderText>false</w:AlwaysShowPlaceholderText>
  <w:DoNotUnderlineInvalidXML/>
  <w:Compatibility>
   <w:SelectEntireFieldWithStartOrEnd/>
   <w:UseWord2002TableStyleRules/>
  </w:Compatibility>
  <w:BrowserLevel>MicrosoftInternetExplorer4</w:BrowserLevel>
 </w:WordDocument>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:LatentStyles DefLockedState="false" LatentStyleCount="156">
 </w:LatentStyles>
</xml><![endif]-->
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:Tahoma;
	panose-1:2 11 6 4 3 5 4 4 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:1627421319 -2147483648 8 0 66047 0;}
@font-face
	{font-family:Verdana;
	panose-1:2 11 6 4 3 5 4 4 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:536871559 0 0 0 415 0;}
@font-face
	{font-family:TahomaH;
	panose-1:0 0 0 0 0 0 0 0 0 0;
	mso-font-alt:Arial;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-format:other;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{mso-style-parent:"";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
h1
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:1;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-font-kerning:0pt;}
h2
	{mso-style-next:Normal;
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:2;
	font-size:9.0pt;
	font-family:Tahoma;}
h3
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	mso-line-height-alt:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:3;
	layout-grid-mode:char;
	font-size:14.0pt;
	font-family:Tahoma;
	font-weight:normal;
	font-style:italic;}
h4
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:4;
	font-size:9.0pt;
	font-family:Tahoma;
	font-weight:normal;}
h5
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:5;
	font-size:9.0pt;
	font-family:Tahoma;}
h6
	{mso-style-next:Normal;
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.3pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:6;
	font-size:9.0pt;
	font-family:Tahoma;
	font-style:italic;}
p.MsoHeading7, li.MsoHeading7, div.MsoHeading7
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:7;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-style:italic;}
p.MsoHeading8, li.MsoHeading8, div.MsoHeading8
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:8;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.MsoHeading9, li.MsoHeading9, div.MsoHeading9
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:9;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.MsoFootnoteText, li.MsoFootnoteText, div.MsoFootnoteText
	{mso-style-noshow:yes;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoHeader, li.MsoHeader, div.MsoHeader
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	tab-stops:right 411.1pt;
	border:none;
	mso-border-bottom-alt:solid windowtext .5pt;
	padding:0in;
	mso-padding-alt:0in 0in 1.0pt 0in;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoFooter, li.MsoFooter, div.MsoFooter
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	tab-stops:center 3.0in right 6.0in;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoCaption, li.MsoCaption, div.MsoCaption
	{mso-style-noshow:yes;
	mso-style-next:Normal;
	margin-top:12.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
span.MsoFootnoteReference
	{mso-style-noshow:yes;
	vertical-align:super;}
span.MsoCommentReference
	{mso-style-noshow:yes;
	mso-ansi-font-size:8.0pt;
	mso-bidi-font-size:8.0pt;}
span.MsoPageNumber
	{mso-ansi-font-size:9.0pt;
	mso-bidi-font-size:9.0pt;
	font-family:Tahoma;
	mso-ascii-font-family:Tahoma;
	mso-hansi-font-family:Tahoma;
	mso-bidi-font-family:Tahoma;}
p.MsoTitle, li.MsoTitle, div.MsoTitle
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:TahomaH;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:TahomaH;
	font-weight:bold;}
p.MsoBodyText, li.MsoBodyText, div.MsoBodyText
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoBodyText2, li.MsoBodyText2, div.MsoBodyText2
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:2.0in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-2.0in;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoBodyText3, li.MsoBodyText3, div.MsoBodyText3
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoBodyTextIndent2, li.MsoBodyTextIndent2, div.MsoBodyTextIndent2
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:14.2pt;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-style:italic;}
p.MsoBodyTextIndent3, li.MsoBodyTextIndent3, div.MsoBodyTextIndent3
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:56.7pt;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-14.15pt;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	mso-layout-grid-align:none;
	punctuation-wrap:simple;
	text-autospace:none;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoDocumentMap, li.MsoDocumentMap, div.MsoDocumentMap
	{mso-style-noshow:yes;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	background:navy;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.1, li.1, div.1
	{mso-style-name:1;
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:0in;
	text-align:center;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.1nho, li.1nho, div.1nho
	{mso-style-name:1nho;
	margin-top:3.5pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.2, li.2, div.2
	{mso-style-name:2;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:8.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.3, li.3, div.3
	{mso-style-name:3;
	mso-style-parent:2;
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.5, li.5, div.5
	{mso-style-name:5;
	mso-style-parent:2;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:8.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-style:italic;}
p.bai, li.bai, div.bai
	{mso-style-name:bai;
	mso-style-parent:"Heading 2";
	margin-top:25.0pt;
	margin-right:0in;
	margin-bottom:10.0pt;
	margin-left:0in;
	text-align:center;
	line-height:10.4pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:2;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.BodyText21, li.BodyText21, div.BodyText21
	{mso-style-name:"Body Text 21";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	mso-line-height-alt:10.5pt;
	mso-pagination:widow-orphan;
	font-size:14.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.cach0, li.cach0, div.cach0
	{mso-style-name:"cach0\,4";
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.chucach, li.chucach, div.chucach
	{mso-style-name:chucach;
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.normal1, li.normal1, div.normal1
	{mso-style-name:normal1;
	mso-style-parent:"cach0\,4";
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.Style1, li.Style1, div.Style1
	{mso-style-name:Style1;
	mso-style-parent:"Heading 2";
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:48.2pt;
	text-align:justify;
	text-indent:-17.0pt;
	line-height:150%;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:2;
	tab-stops:list 49.2pt;
	font-size:14.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;
	text-decoration:underline;
	text-underline:single;}
@page Section1
	{size:8.5in 11.0in;
	margin:1.0in 1.25in 1.0in 1.25in;
	mso-header-margin:.5in;
	mso-footer-margin:.5in;
	mso-paper-source:0;}
div.Section1
	{page:Section1;}
-->
</style>
<!--[if gte mso 10]>
<style>
 /* Style Definitions */
 table.MsoNormalTable
	{mso-style-name:"Table Normal";
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-noshow:yes;
	mso-style-parent:"";
	mso-padding-alt:0in 5.4pt 0in 5.4pt;
	mso-para-margin:0in;
	mso-para-margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:"Times New Roman";
	mso-ansi-language:#0400;
	mso-fareast-language:#0400;
	mso-bidi-language:#0400;}
</style>
<![endif]-->
</head>

<body lang=EN-US style='tab-interval:.5in'>

<div class=Section1>

<h1 align=center style='text-align:center;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:15.0pt;line-height:150%;font-family:
Verdana'>DACARBAZIN<o:p></o:p></span></h1>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><b><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Tên
chung qu&#7889;c t&#7871;:</span></b><span style='mso-bidi-font-size:14.0pt;
line-height:150%;font-family:Verdana'> Dacarbazine.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><b><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Mã ATC:</span></b><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'> L01A
X04.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><b><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Lo&#7841;i
thu&#7889;c:</span></b><span style='mso-bidi-font-size:14.0pt;line-height:150%;
font-family:Verdana'> Ch&#7889;ng ung th&#432;.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><b><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>D&#7841;ng
thu&#7889;c và hàm l&#432;&#7907;ng:</span></b><span style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'> L&#7885; 100 mg, 200 mg
dacarbazin &#273;&#7875; tiêm.<o:p></o:p></span></p>

<p class=normal1 align=left style='margin-top:0in;text-align:left;line-height:
150%'><span style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>D&#432;&#7907;c
lý và c&#417; ch&#7871; tác d&#7909;ng<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Dacarbazin
là dimethyltriazen - imidazol - carboxamid (DTIC) có tác d&#7909;ng ch&#7889;ng
ung th&#432;. Thu&#7889;c &#273;ã t&#7915;ng &#273;&#432;&#7907;c coi là m&#7897;t
ch&#7845;t ch&#7889;ng chuy&#7875;n hóa, tác d&#7909;ng b&#7857;ng cách &#7913;c
ch&#7871; chuy&#7875;n hóa purin và t&#7893;ng h&#7907;p acid nucleic.
Nh&#432;ng trong c&#417; th&#7875;, dacarbazin &#273;&#432;&#7907;c chuy&#7875;n
hóa m&#7841;nh b&#7903;i h&#7879; th&#7889;ng cytochrom P<sub>450</sub> &#7903;
gan, nh&#7901; ph&#7843;n &#7913;ng kh&#7917; methyl. Sau &#273;ó d&#7851;n xu&#7845;t
monomethyl t&#7921; tách ra thành 5 - aminoimidazol - 4 - carboxamid (AIC) và m&#7897;t
h&#7907;p ch&#7845;t trung gian, có l&#7869; là diazomethan, ch&#7845;t này
phân gi&#7843;i &#273;&#7875; t&#7841;o ra ion methyl carbonium. Ion này g&#7855;n
vào các nhóm ái nhân trên acid nucleic và các &#273;&#7841;i phân t&#7917;
khác; nh&#432; v&#7853;y tác &#273;&#7897;ng nh&#432; m&#7897;t tác nhân alkyl
hóa. V&#7883; trí 7 c&#7911;a guanin trên DNA &#273;&#7863;c bi&#7879;t d&#7877;
b&#7883; alkyl hóa.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Dacarbazin
&#273;&#432;&#7907;c coi là m&#7897;t tác nhân alkyl hóa, gây c&#7843;n tr&#7903;
s&#7921; t&#7893;ng h&#7907;p DNA, RNA và protein. Nhìn chung, thu&#7889;c có
tác d&#7909;ng m&#7841;nh nh&#7845;t là &#7913;c ch&#7871; t&#7893;ng h&#7907;p
RNA. Dacarbazin di&#7879;t các t&#7871; bào m&#7897;t cách ch&#7853;m ch&#7841;p
và không th&#7845;y có tác d&#7909;ng gi&#7843;m mi&#7877;n d&#7883;ch &#7903;
ng&#432;&#7901;i.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Dacarbazin
liên k&#7871;t r&#7845;t ít v&#7899;i protein huy&#7871;t t&#432;&#417;ng (x&#7845;p
x&#7881; 5%). N&#7917;a &#273;&#7901;i c&#7911;a thu&#7889;c trong huy&#7871;t
t&#432;&#417;ng kho&#7843;ng 35 phút sau khi tiêm t&#297;nh m&#7841;ch. &#7903;
ng&#432;&#7901;i b&#7879;nh b&#7883; b&#7879;nh gan ho&#7863;c th&#7853;n, n&#7917;a
&#273;&#7901;i c&#7911;a thu&#7889;c b&#7883; kéo dài. Sáu gi&#7901; sau khi
tiêm, 40% l&#432;&#7907;ng thu&#7889;c &#273;&#432;&#7907;c &#273;ào th&#7843;i
qua n&#432;&#7899;c ti&#7875;u, trong &#273;ó m&#7897;t n&#7917;a &#7903; d&#7841;ng
không bi&#7871;n &#273;&#7893;i.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Dacarbazin
qua &#273;&#432;&#7907;c hàng rào máu - não v&#7899;i m&#7913;c &#273;&#7897;
nh&#7845;t &#273;&#7883;nh; n&#7891;ng &#273;&#7897; trong d&#7883;ch não t&#7911;y
b&#7857;ng kho&#7843;ng 14% n&#7891;ng &#273;&#7897; &#7903; huy&#7871;t
t&#432;&#417;ng. Ng&#432;&#7901;i ta không bi&#7871;t dacarbazin có vào nhau
thai ho&#7863;c bài ti&#7871;t qua s&#7919;a hay không.<o:p></o:p></span></p>

<p class=normal1 align=left style='margin-top:0in;text-align:left;line-height:
150%'><span style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Ch&#7881;
&#273;&#7883;nh<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Dacarbazin
&#273;&#432;&#7907;c ch&#7881; &#273;&#7883;nh dùng &#273;&#417;n &#273;&#7897;c
trong &#273;i&#7873;u tr&#7883; u melanin (u h&#7855;c t&#7889;) ác tính di
c&#259;n, sarcoma, và dùng ph&#7889;i h&#7907;p v&#7899;i các thu&#7889;c tr&#7883;
ung th&#432; khác trong các carcinoma ru&#7897;t k&#7871;t, bu&#7891;ng tr&#7913;ng,
vú, ph&#7893;i, tinh hoàn, m&#7897;t s&#7889; u &#273;&#7863;c &#7903; tr&#7867;
em và b&#7879;nh Hodgkin.<o:p></o:p></span></p>

<p class=normal1 align=left style='margin-top:0in;text-align:left;line-height:
150%'><span style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Ch&#7889;ng
ch&#7881; &#273;&#7883;nh<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Dacarbazin
ch&#7889;ng ch&#7881; &#273;&#7883;nh &#7903; nh&#7919;ng ng&#432;&#7901;i b&#7879;nh
&#273;ã có ti&#7873;n s&#7917; quá m&#7851;n c&#7843;m v&#7899;i thu&#7889;c
này.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Dacarbazin
không &#273;&#432;&#7907;c dùng cho nh&#7919;ng ng&#432;&#7901;i b&#7879;nh có
thai ho&#7863;c s&#7855;p có thai, nh&#7919;ng ng&#432;&#7901;i m&#7865; cho
con bú, nh&#7919;ng ng&#432;&#7901;i &#273;ã b&#7883; suy t&#7911;y n&#7863;ng.<o:p></o:p></span></p>

<p class=normal1 align=left style='margin-top:0in;text-align:left;line-height:
150%'><span style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Th&#7853;n
tr&#7885;ng <o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Thu&#7889;c
ra ngoài m&#7841;ch khi tiêm t&#297;nh m&#7841;ch có th&#7875; gây t&#7893;n
th&#432;&#417;ng mô và r&#7845;t &#273;au. Ðau t&#7841;i ch&#7895;, c&#7843;m
giác rát b&#7887;ng và kích &#7913;ng da &#7903; n&#417;i tiêm có th&#7875; d&#7883;u
&#273;i n&#7871;u &#273;&#432;&#7907;c ch&#432;&#7901;m nóng t&#7841;i ch&#7895;.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Tránh ti&#7871;p
xúc v&#7899;i da và m&#7855;t khi dùng dacarbazin.<o:p></o:p></span></p>

<p class=normal1 align=left style='margin-top:0in;text-align:left;line-height:
150%'><span style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Th&#7901;i
k&#7923; mang thai<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Khi dùng
cho &#273;&#7897;ng v&#7853;t, thu&#7889;c này gây ung th&#432; bi&#7875;u mô
và quái thai, nh&#432;ng ch&#432;a có thông báo nào mô t&#7843; dùng dacarbazin
gây ung th&#432; ho&#7863;c quái thai trên ng&#432;&#7901;i. <o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Ti&#7871;p
xúc ngh&#7873; nghi&#7879;p c&#7911;a ph&#7909; n&#7919; &#273;&#7889;i v&#7899;i
tác nhân ch&#7889;ng ung th&#432; trong khi mang thai có th&#7875; gây nguy hi&#7875;m
cho thai nhi.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Trong
khi &#273;i&#7873;u tr&#7883; và m&#7897;t tháng sau khi k&#7871;t thúc &#273;i&#7873;u
tr&#7883; nên dùng thu&#7889;c tránh thai.<o:p></o:p></span></p>

<p class=normal1 align=left style='margin-top:0in;text-align:left;line-height:
150%'><span style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Th&#7901;i
k&#7923; cho con bú<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Trong th&#7901;i
gian &#273;i&#7873;u tr&#7883; v&#7899;i thu&#7889;c ch&#7889;ng ung th&#432;
nên ng&#7915;ng cho con bú.<o:p></o:p></span></p>

<p class=normal1 align=left style='margin-top:0in;text-align:left;line-height:
150%'><span style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Tác
d&#7909;ng không mong mu&#7889;n (ADR)<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Suy t&#7911;y
tr&#432;&#7899;c &#273;ây &#273;&#432;&#7907;c coi là tác d&#7909;ng ph&#7909;
nghiêm tr&#7885;ng nh&#7845;t. Nh&#432;ng th&#7921;c t&#7871; suy t&#7911;y
nghiêm tr&#7885;ng ít g&#7863;p &#7903; nh&#7919;ng li&#7873;u &#273;&#432;&#7907;c
khuy&#7871;n cáo (&#273;i&#7873;u tr&#7883; 5 ngày v&#7899;i 200 - 300 mg/m<sup>2</sup>/ngày).
Suy t&#7911;y là tác d&#7909;ng ph&#7909; n&#7863;ng, &#273;ôi khi nguy hi&#7875;m
&#273;&#7871;n tính m&#7841;ng. Vì th&#7871; khi &#273;i&#7873;u tr&#7883; b&#7857;ng
dacarbazin c&#7847;n liên t&#7909;c ki&#7875;m tra công th&#7913;c máu. S&#7889;
l&#432;&#7907;ng b&#7841;ch c&#7847;u xu&#7889;ng th&#7845;p nh&#7845;t
th&#432;&#7901;ng kho&#7843;ng 3 tu&#7847;n sau khi b&#7855;t &#273;&#7847;u
&#273;i&#7873;u tr&#7883;.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Ho&#7841;i
t&#7917; gan gây t&#7917; vong cùng v&#7899;i t&#7855;c ngh&#7869;n huy&#7871;t
kh&#7889;i &#7891; &#7841;t các t&#297;nh m&#7841;ch nh&#7887; và trung bình &#7903;
m&#7897;t s&#7889; ng&#432;&#7901;i b&#7879;nh. Ðây là tác d&#7909;ng ph&#7909;
r&#7845;t nghiêm tr&#7885;ng. Transaminase t&#259;ng cao g&#7863;p ít nh&#7845;t
kho&#7843;ng 50% s&#7889; ng&#432;&#7901;i b&#7879;nh. Nguy c&#417; &#273;&#7897;c
tính trên gan gây ch&#7871;t ng&#432;&#7901;i (&#432;&#7899;c tính kho&#7843;ng
0,01%) c&#7847;n &#273;&#432;&#7907;c quan tâm &#273;&#7847;y &#273;&#7911; khi
&#273;i&#7873;u tr&#7883;.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Chán
&#259;n, bu&#7891;n nôn và nôn là các ph&#7843;n &#7913;ng ph&#7909; th&#432;&#7901;ng
g&#7863;p nh&#7845;t, chi&#7871;m h&#417;n 90% s&#7889; ng&#432;&#7901;i b&#7879;nh,
th&#432;&#7901;ng g&#7863;p khi b&#7855;t &#273;&#7847;u &#273;i&#7873;u tr&#7883;,
nh&#432;ng có th&#7875; gi&#7843;m m&#7913;c &#273;&#7897; sau nh&#7919;ng ngày
&#273;&#7847;u.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><i><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Th&#432;&#7901;ng
g&#7863;p, ADR &gt; 1/100<o:p></o:p></span></i></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Máu: Gi&#7843;m
b&#7841;ch c&#7847;u,gi&#7843;m ti&#7875;u c&#7847;u.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Tiêu
hóa: Chán &#259;n, bu&#7891;n nôn, nôn.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Tác d&#7909;ng
khác: Ðau sau khi tiêm t&#297;nh m&#7841;ch.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><i><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Ít g&#7863;p,
1/1000 &lt; ADR &lt; 1/100<o:p></o:p></span></i></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Toàn
thân: Tình tr&#7841;ng gi&#7889;ng nh&#432; cúm (s&#7889;t, &#273;au c&#417;).<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>Da: Ngo&#7841;i ban, ban &#273;&#7887;.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>C&#417;: Li&#7879;t nh&#7865; m&#7863;t.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>Tác d&#7909;ng khác: R&#7909;ng tóc.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><i><span
lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>Hi&#7871;m g&#7863;p, ADR &lt; 1/1000<o:p></o:p></span></i></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>Toàn thân: Ph&#7843;n v&#7879;.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>Máu: Thi&#7871;u máu.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>Tiêu hóa: &#7881;a ch&#7843;y.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>Da: Nh&#7841;y c&#7843;m ánh sáng.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>Gan (nguy k&#7883;ch): Nhi&#7877;m &#273;&#7897;c gan gây
ch&#7871;t ng&#432;&#7901;i là h&#7853;u qu&#7843; c&#7911;a huy&#7871;t kh&#7889;i
t&#7855;c t&#297;nh m&#7841;ch gan và ho&#7841;i t&#7917; t&#7871; bào gan.<o:p></o:p></span></p>

<p class=normal1 align=left style='margin-top:0in;text-align:left;line-height:
150%'><span lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;
font-family:Verdana;mso-ansi-language:DE'>H&#432;&#7899;ng d&#7851;n cách x&#7917;
trí ADR<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>N&#7871;u ng&#432;&#7901;i b&#7879;nh không &#259;n không
u&#7889;ng quá nhi&#7873;u trong kho&#7843;ng 4 - 6 gi&#7901; tr&#432;&#7899;c
khi &#273;i&#7873;u tr&#7883;, có th&#7875; gi&#7843;m m&#7913;c &#273;&#7897;
bu&#7891;n nôn và nôn. Các thu&#7889;c ch&#7889;ng nôn c&#361;ng có tác d&#7909;ng
t&#7889;t n&#7871;u &#273;&#432;&#7907;c dùng tr&#432;&#7899;c khi tiêm
dacarbazin. Tình tr&#7841;ng gi&#7889;ng cúm th&#432;&#7901;ng x&#7843;y ra 1
tu&#7847;n sau li&#7873;u &#273;&#417;n dacarbazin, th&#432;&#7901;ng kéo dài 1
- 3 tu&#7847;n và có th&#7875; tr&#7903; l&#7841;i sau l&#7847;n &#273;i&#7873;u
tr&#7883; ti&#7871;p b&#7857;ng dacarbazin.<o:p></o:p></span></p>

<p class=normal1 align=left style='margin-top:0in;text-align:left;line-height:
150%'><span lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;
font-family:Verdana;mso-ansi-language:DE'>Li&#7873;u l&#432;&#7907;ng và cách
dùng<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>U melanin ác tính:<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>Li&#7873;u th&#432;&#7901;ng dùng: Tiêm t&#297;nh m&#7841;ch
2 - 4,5 mg/kg th&#7875; tr&#7885;ng/ngày, trong 10 ngày. Có th&#7875; nh&#7855;c
l&#7841;i c&#7913; 4 tu&#7847;n 1 &#273;&#7907;t. M&#7897;t cách dùng khác là
theo li&#7873;u 250 mg/m<sup>2</sup> di&#7879;n tích c&#417; th&#7875;/ngày,
tiêm t&#297;nh m&#7841;ch trong 5 ngày, có th&#7875; nh&#7855;c l&#7841;i c&#7913;
3 tu&#7847;n 1 &#273;&#7907;t. Li&#7873;u dùng cho tr&#7867; em: ch&#432;a
&#273;&#432;&#7907;c xác &#273;&#7883;nh.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>B&#7879;nh Hodgkin:<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>Trong &#273;i&#7873;u tr&#7883; b&#7879;nh Hodgkin, dùng
k&#7871;t h&#7907;p v&#7899;i các thu&#7889;c tr&#7883; ung th&#432; khác: Tiêm
t&#297;nh m&#7841;ch v&#7899;i li&#7873;u 150 mg/m<sup>2</sup> di&#7879;n tích
c&#417; th&#7875;/ngày, trong 5 ngày, có th&#7875; nh&#7855;c l&#7841;i c&#7913;
4 tu&#7847;n 1 &#273;&#7907;t; ho&#7863;c tiêm t&#297;nh m&#7841;ch 375 mg/m<sup>2</sup>
di&#7879;n tích c&#417; th&#7875;/ngày, vào ngày th&#7913; nh&#7845;t khi dùng
k&#7871;t h&#7907;p v&#7899;i thu&#7889;c khác, c&#7913; 15 ngày nh&#7855;c l&#7841;i
1 l&#7847;n.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>Ghi chú: Dacarbazin 100 mg/l&#7885; và 200 mg/l&#7885;
&#273;&#432;&#7907;c pha v&#7899;i 9,9 ml và 19,7 ml n&#432;&#7899;c c&#7845;t
pha tiêm &#273;&#7875; &#273;&#432;&#7907;c dung d&#7883;ch có 10 mg/ml
dacarbazin có pH 3,0 &#273;&#7871;n 4,0. Li&#7873;u tính toán t&#7915; dung d&#7883;ch
này &#273;&#432;&#7907;c hút vào b&#417;m tiêm r&#7891;i tiêm t&#297;nh m&#7841;ch
trong vòng 1 - 2 phút. Dung d&#7883;ch này có th&#7875; pha loãng ti&#7871;p b&#7857;ng
dung d&#7883;ch glucose 5% ho&#7863;c natri clorid 0,9% &#273;&#7875; truy&#7873;n
t&#297;nh m&#7841;ch trong vòng 15 - 30 phút.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>H&#432;&#7899;ng d&#7851;n s&#7917; d&#7909;ng: <o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>Dacarbazin &#273;&#7875; tiêm ph&#7843;i &#273;&#432;&#7907;c
chu&#7849;n b&#7883; trong &#273;i&#7873;u ki&#7879;n vô khu&#7849;n, và khi
tiêm cho ng&#432;&#7901;i b&#7879;nh ph&#7843;i do nh&#7919;ng ng&#432;&#7901;i
&#273;ã &#273;&#432;&#7907;c hu&#7845;n luy&#7879;n k&#7929; th&#7921;c hi&#7879;n.
Khi thu&#7889;c r&#7899;t ra ngoài, k&#7929; thu&#7853;t viên c&#7847;n &#273;i
g&#259;ng tay lau chùi s&#7841;ch thu&#7889;c b&#7883; r&#417;i vãi b&#7857;ng
b&#7885;t bi&#7875;n, v&#7913;t b&#7885;t bi&#7875;n vào túi ch&#7845;t d&#7867;o
và r&#7917;a b&#7857;ng n&#432;&#7899;c nhi&#7873;u l&#7847;n vùng r&#417;i vãi
thu&#7889;c. Các túi b&#7857;ng ch&#7845;t d&#7867;o &#273;&#7921;ng b&#7885;t
bi&#7875;n b&#7849;n c&#7847;n hàn kín r&#7891;i &#273;em &#273;&#7889;t
&#273;i và &#273;&#7891;ng th&#7901;i h&#7911;y các bao tay. Tr&#432;&#7901;ng
h&#7907;p truy&#7873;n thu&#7889;c ra ngoài m&#7841;ch, th&#432;&#7901;ng
&#273;au và có nguy c&#417; ho&#7841;i t&#7917;, c&#7847;n ng&#7915;ng truy&#7873;n
ngay l&#7853;p t&#7913;c và ti&#7871;p t&#7909;c truy&#7873;n qua t&#297;nh m&#7841;ch
khác.<o:p></o:p></span></p>

<p class=normal1 align=left style='margin-top:0in;text-align:left;line-height:
150%'><span lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;
font-family:Verdana;mso-ansi-language:DE'>T&#432;&#417;ng tác thu&#7889;c<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>Các ch&#7845;t gây c&#7843;m &#7913;ng enzym gan nh&#432;
barbiturat, rifampicin, phenytoin có th&#7875; thúc &#273;&#7849;y s&#7921; ho&#7841;t
hóa dacarbazin thành aminoimidazol - carboxamid. Dacarbazin &#7913;c ch&#7871;
xanthin oxidase và có kh&#7843; n&#259;ng ho&#7841;t hóa các thu&#7889;c
nh&#432; mercaptopurin, azathioprin, allopurinol. Nh&#7919;ng ng&#432;&#7901;i
b&#7879;nh dùng dacarbazin không nên tiêm ch&#7911;ng v&#7899;i các vaccin s&#7889;ng:
Dacarbazin có th&#7875; gây h&#7841;i cho s&#7921; &#273;áp &#7913;ng mi&#7877;n
d&#7883;ch &#273;&#7889;i v&#7899;i vaccin và t&#259;ng các tác d&#7909;ng
không mong mu&#7889;n c&#7911;a vaccin.<o:p></o:p></span></p>

<p class=normal1 align=left style='margin-top:0in;text-align:left;line-height:
150%'><span lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;
font-family:Verdana;mso-ansi-language:DE'>Ð&#7897; &#7893;n &#273;&#7883;nh và
b&#7843;o qu&#7843;n <o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>Dung d&#7883;ch ch&#432;a pha loãng &#273;&#432;&#7907;c
b&#7843;o qu&#7843;n &#7903; 4<sup>o</sup>C trong 72 gi&#7901; ho&#7863;c &#7903;
nhi&#7879;t &#273;&#7897; phòng bình th&#432;&#7901;ng trong t&#7889;i &#273;a
8 gi&#7901;. B&#7843;o qu&#7843;n các &#7889;ng thu&#7889;c b&#7897;t
&#273;&#432;&#7907;c 3 n&#259;m trong &#273;i&#7873;u ki&#7879;n nhi&#7879;t
&#273;&#7897; 2 - 8<sup>0</sup>C và tránh ánh sáng.<span style='mso-tab-count:
1'>           </span><o:p></o:p></span></p>

<p class=normal1 align=left style='margin-top:0in;text-align:left;line-height:
150%'><span lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;
font-family:Verdana;mso-ansi-language:DE'>T&#432;&#417;ng k&#7925;<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>Dacarbazin t&#432;&#417;ng k&#7925; v&#7899;i
hydrocortison natri sucinat nh&#432;ng không t&#432;&#417;ng k&#7925; v&#7899;i
hydrocortison natri phosphat; thu&#7889;c còn t&#432;&#417;ng k&#7925; v&#7899;i
heparin tuy r&#7857;ng ch&#7881; v&#7899;i dung d&#7883;ch dacarbazin &#273;&#7853;m
&#273;&#7863;c (25 mg/ml). Ð&#7875; tránh &#273;au khi tiêm truy&#7873;n t&#297;nh
m&#7841;ch, dung d&#7883;ch c&#7847;n &#273;&#432;&#7907;c pha loãng v&#7899;i
dung d&#7883;ch glucose 5% ho&#7863;c dung d&#7883;ch natri clorid 0,9% và truy&#7873;n
trong 15 - 30 phút.<o:p></o:p></span></p>

<p class=normal1 align=left style='margin-top:0in;text-align:left;line-height:
150%'><span lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;
font-family:Verdana;mso-ansi-language:DE'>Quá li&#7873;u và x&#7917; trí<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>Tri&#7879;u ch&#7913;ng: Suy t&#7911;y x&#432;&#417;ng và
các tác d&#7909;ng trên h&#7879; tiêu hóa nh&#432; bu&#7891;n nôn, nôn, &#7881;a
ch&#7843;y có th&#7875; x&#7843;y ra.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>Ði&#7873;u tr&#7883;: Ng&#7915;ng dùng dacarbazin và truy&#7873;n
máu &#273;&#7889;i v&#7899;i suy t&#7911;y x&#432;&#417;ng.<o:p></o:p></span></p>

<p class=cach0 align=left style='margin-top:0in;text-align:left;line-height:
150%'><span style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Thông
tin qui ch&#7871;<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Thu&#7889;c
&#273;&#7897;c b&#7843;ng A.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'><o:p>&nbsp;</o:p></span></p>

</div>

</body>


<!-- Mirrored from medicain.net/DUOC THU QUOC GIA/Dacarbazin.htm by HTTrack Website Copier/3.x [XR&CO'2013], Tue, 25 Mar 2014 18:06:49 GMT -->
</html>
